You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

Details for Patent: 11,234,938


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,234,938 protect, and when does it expire?

Patent 11,234,938 protects VELPHORO and is included in one NDA.

Protection for VELPHORO has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has twenty-nine patent family members in seventeen countries.

Summary for Patent: 11,234,938
Title:Pharmaceutical composition, comprising phosphate binder particles
Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
Inventor(s): Chofflon; Laurent (Zurich, CH), Philipp; Erik (Arbon, CH)
Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd. (St. Gallen, CH)
Application Number:16/820,190
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

Drugs Protected by US Patent 11,234,938

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vifor Fresenius VELPHORO ferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 11,234,938

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
13194632Nov 27, 2013
14156793Feb 26, 2014

International Family Members for US Patent 11,234,938

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014356500 ⤷  Sign Up
Australia 2020217386 ⤷  Sign Up
Australia 2022204380 ⤷  Sign Up
Canada 2931173 ⤷  Sign Up
China 105764492 ⤷  Sign Up
Cyprus 1123956 ⤷  Sign Up
Denmark 3073997 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.